Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases
PMID: 39633231
Source: Dig Dis Sci
Publication date:
2025-07-24
Year:
2025
Abstract
NULL